SCHEMBL2569722

SCHEMBL2569722

COc1ccc(-c2cnc3nnn(Cc4cccc5cccnc45)c3n2)cc1

nearest known ligand 0.61

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MET P08581 18/20 0.61
CNR2 P34972 1/20 0.43
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
KCNH2 Q12809 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2572904 0.90 MET (0.49) METPSEN1PSEN2KCNH2APH1B
SCHEMBL2574066 0.86 MET (0.56) MET
SCHEMBL2572670 0.85 MET (0.56) MET
SCHEMBL2572016 0.84 MET (0.68) MET
SCHEMBL2566584 0.82 MET (0.70) MET
SCHEMBL2569486 0.80 MET (0.77) MET
SCHEMBL12689701 0.78 MET (0.58) MET
SCHEMBL2572265 0.78 MET (0.48) MET
SCHEMBL2013882 0.77 MET (0.72) MET
SCHEMBL16587168 0.74 MET (0.67) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018383-B1 TRIAZOLOPYRAZINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS PFIZER PROD INC (US) 2011-11-09 EP claimed